Compare Stocks: ZBH, PEN, BSX, and BDX

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BDX Becton, Dickinson and Company	$189.71 +0.8%	$166.14	$127.59 ▼ $193.07	$51.84B	0.19	1.82 million shs	1.69 million shs
BSX Boston Scientific	$46.82 +0.3%	$46.56	$42.20 ▼ $109.50	$67.64B	0.56	19.52 million shs	17.14 million shs
PEN Penumbra	$321.58 +0.2%	$320.71	$221.26 ▼ $362.41	$12.64B	0.7	267,554 shs	234,126 shs
ZBH Zimmer Biomet	$101.10 +1.6%	$93.88	$79.12 ▼ $106.88	$18.97B	0.45	2.26 million shs	1.19 million shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BDX Becton, Dickinson and Company	+0.85%	-1.17%	+12.55%	+28.94%	-2.96%
BSX Boston Scientific	+0.38%	-7.08%	+1.64%	-3.10%	-55.81%
PEN Penumbra	+0.02%	-1.09%	+0.49%	+0.98%	+20.04%
ZBH Zimmer Biomet	+1.71%	+0.09%	+3.98%	+22.61%	-5.40%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
BDX Becton, Dickinson and Company	$189.71 +0.8%	$166.14	$127.59 ▼ $193.07	$51.84B	0.19	1.82 million shs	1.69 million shs
BSX Boston Scientific	$46.82 +0.3%	$46.56	$42.20 ▼ $109.50	$67.64B	0.56	19.52 million shs	17.14 million shs
PEN Penumbra	$321.58 +0.2%	$320.71	$221.26 ▼ $362.41	$12.64B	0.7	267,554 shs	234,126 shs
ZBH Zimmer Biomet	$101.10 +1.6%	$93.88	$79.12 ▼ $106.88	$18.97B	0.45	2.26 million shs	1.19 million shs

The 10 Best High-Yield Dividend Stocks for 2026

Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
BDX Becton, Dickinson and Company	+0.85%	-1.17%	+12.55%	+28.94%	-2.96%
BSX Boston Scientific	+0.38%	-7.08%	+1.64%	-3.10%	-55.81%
PEN Penumbra	+0.02%	-1.09%	+0.49%	+0.98%	+20.04%
ZBH Zimmer Biomet	+1.71%	+0.09%	+3.98%	+22.61%	-5.40%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
BDX Becton, Dickinson and Company	2.41	Hold	$185.67	-2.13% Downside
BSX Boston Scientific	2.71	Moderate Buy	$71.62	52.96% Upside
PEN Penumbra	2.18	Hold	$367.07	14.15% Upside
ZBH Zimmer Biomet	2.26	Hold	$104.42	3.28% Upside

Current Analyst Ratings Breakdown

Latest ZBH, PEN, BSX, and BDX Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/25/2026	BSX Boston Scientific	TD Cowen Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy	$56.00
8/25/2026	ZBH Zimmer Biomet	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/24/2026	PEN Penumbra	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Strong Sell ➝ Hold
8/13/2026	BDX Becton, Dickinson and Company	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Buy
8/13/2026	BDX Becton, Dickinson and Company	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Sector Perform	$180.00 ➝ $190.00
8/10/2026	ZBH Zimmer Biomet	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Hold	$83.00 ➝ $100.00
8/7/2026	BDX Becton, Dickinson and Company	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D+)
8/7/2026	BDX Becton, Dickinson and Company	Stifel Nicolaus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Set Price Target		$195.00
8/7/2026	BDX Becton, Dickinson and Company	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Sector Perform	$175.00 ➝ $180.00
8/7/2026	BDX Becton, Dickinson and Company	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sector Perform ➝ Hold
8/7/2026	BDX Becton, Dickinson and Company	Citigroup Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$198.00 ➝ $204.00

(Data available from 8/29/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
BDX Becton, Dickinson and Company	$21.84B	2.39	$23.28 per share	8.15	$88.61 per share	2.14
BSX Boston Scientific	$20.07B	3.38	$4.05 per share	11.56	$17.37 per share	2.70
PEN Penumbra	$1.40B	9.02	$4.31 per share	74.67	$38.86 per share	8.28
ZBH Zimmer Biomet	$8.23B	2.34	$13.96 per share	7.24	$66.23 per share	1.53

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
BDX Becton, Dickinson and Company	$1.68B	$3.32	57.14	14.33	13.26	4.52%	14.79%	6.93%	11/5/2026 (Estimated)
BSX Boston Scientific	$2.90B	$2.47	18.96	13.69	1.02	17.50%	19.28%	10.89%	10/28/2026 (Estimated)
PEN Penumbra	$177.69M	$4.07	79.01	51.78	1.99	10.67%	10.50%	8.17%	11/4/2026 (Estimated)
ZBH Zimmer Biomet	$705.20M	$4.11	24.60	11.25	2.70	9.48%	13.12%	7.23%	11/4/2026 (Estimated)

Latest ZBH, PEN, BSX, and BDX Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/6/2026	Q3 2026	BDX Becton, Dickinson and Company	$3.14	$3.23	+$0.09	$1.37	$4.89 billion	$4.98 billion
8/5/2026	Q2 2026	ZBH Zimmer Biomet	$2.01	$2.07	+$0.06	$1.03	$2.13 billion	$2.18 billion
7/30/2026	Q2 2026	PEN Penumbra	$1.16	$0.88	-$0.28	$0.88	$389.64 million	$390.05 million
7/29/2026	Q2 2026	BSX Boston Scientific	$0.83	$0.86	+$0.03	$0.61	$5.38 billion	$5.44 billion

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
BDX Becton, Dickinson and Company	$4.20	2.21%	+5.65%	126.51%	53 Years
BSX Boston Scientific	N/A	N/A	N/A	N/A	N/A
PEN Penumbra	N/A	N/A	N/A	N/A	N/A
ZBH Zimmer Biomet	$0.96	0.95%	N/A	23.36%	N/A

Latest ZBH, PEN, BSX, and BDX Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
7/28/2026	BDX Becton, Dickinson and Company	quarterly	$1.05	2.53%	9/9/2026	9/9/2026	9/30/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
BDX Becton, Dickinson and Company	0.55	0.87	0.51
BSX Boston Scientific	0.43	1.24	0.74
PEN Penumbra	0.01	5.75	3.86
ZBH Zimmer Biomet	0.50	1.69	0.94

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
BDX Becton, Dickinson and Company	86.97%
BSX Boston Scientific	89.07%
PEN Penumbra	88.88%
ZBH Zimmer Biomet	88.89%

Insider Ownership

Company	Insider Ownership
BDX Becton, Dickinson and Company	0.40%
BSX Boston Scientific	0.34%
PEN Penumbra	2.90%
ZBH Zimmer Biomet	1.28%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
BDX Becton, Dickinson and Company	72,000	275.54 million	274.44 million	Optionable
BSX Boston Scientific	59,000	1.45 billion	1.44 billion	Optionable
PEN Penumbra	4,700	39.39 million	38.25 million	Optionable
ZBH Zimmer Biomet	17,000	190.74 million	188.30 million	Optionable

ZBH, PEN, BSX, and BDX Headlines

Recent News About These Companies

Jefferies Financial Group Inc. Acquires New Stake in Zimmer Biomet Holdings, Inc. $ZBH

46 minutes ago | marketbeat.com

Canada Pension Plan Investment Board Invests $32.54 Million in Zimmer Biomet Holdings, Inc. $ZBH

2 hours ago | marketbeat.com

Zimmer Biomet Announces Quarterly Dividend for Third Quarter of 2026

August 28 at 4:15 PM | prnewswire.com

Hsbc Holdings PLC Invests $35.42 Million in Zimmer Biomet Holdings, Inc. $ZBH

August 28 at 5:27 AM | marketbeat.com

Legal & General Group Plc Purchases Shares of 1,465,529 Zimmer Biomet Holdings, Inc. $ZBH

August 28 at 5:20 AM | marketbeat.com

OMERS ADMINISTRATION Corp Buys Shares of 10,708 Zimmer Biomet Holdings, Inc. $ZBH

August 28 at 5:12 AM | marketbeat.com

Zimmer Biomet Holdings, Inc. (NYSE:ZBH) Given Average Rating of "Hold" by Analysts

August 28 at 4:28 AM | marketbeat.com

Zacks Research Upgrades Zimmer Biomet (NYSE:ZBH) to Hold

August 27 at 6:35 AM | marketbeat.com

Sanctuary Advisors LLC Makes New $1.78 Million Investment in Zimmer Biomet Holdings, Inc. $ZBH

August 27 at 5:04 AM | marketbeat.com

17,225 Shares in Zimmer Biomet Holdings, Inc. $ZBH Acquired by Bank of Nova Scotia

August 27 at 3:51 AM | marketbeat.com

Commerce Bank Takes Position in Zimmer Biomet Holdings, Inc. $ZBH

August 27 at 3:44 AM | marketbeat.com

Primecap Management Co. CA Takes Position in Zimmer Biomet Holdings, Inc. $ZBH

August 26 at 5:53 AM | marketbeat.com

The Manufacturers Life Insurance Company Makes New $125.54 Million Investment in Zimmer Biomet Holdings, Inc. $ZBH

August 26 at 5:36 AM | marketbeat.com

Parkman Healthcare Partners LLC Invests $20.02 Million in Zimmer Biomet Holdings, Inc. $ZBH

August 25, 2026 | marketbeat.com

32,146 Shares in Zimmer Biomet Holdings, Inc. $ZBH Acquired by Korea Investment CORP

August 25, 2026 | marketbeat.com

Bank of New York Mellon Corp Takes Position in Zimmer Biomet Holdings, Inc. $ZBH

August 25, 2026 | marketbeat.com

Magellan Asset Management Ltd Takes Position in Zimmer Biomet Holdings, Inc. $ZBH

August 24, 2026 | marketbeat.com

Ally Financial Inc. Invests $1.72 Million in Zimmer Biomet Holdings, Inc. $ZBH

August 24, 2026 | marketbeat.com

22,371 Shares in Zimmer Biomet Holdings, Inc. $ZBH Purchased by B. Metzler seel. Sohn & Co. AG

August 23, 2026 | marketbeat.com

NewEdge Wealth LLC Makes New Investment in Zimmer Biomet Holdings, Inc. $ZBH

August 22, 2026 | marketbeat.com

Callan Family Office LLC Takes $5.77 Million Position in Zimmer Biomet Holdings, Inc. $ZBH

August 22, 2026 | marketbeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

ZBH, PEN, BSX, and BDX Company Descriptions

Becton, Dickinson and Company NYSE:BDX

$189.71 +1.58 (+0.84%)

As of 08/28/2026 03:58 PM Eastern

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; and prefillable drug delivery systems. The BD Life Sciences segment offers specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The BD Interventional segment provides hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.

Boston Scientific NYSE:BSX

$46.82 +0.15 (+0.32%)

As of 08/28/2026 03:58 PM Eastern

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Penumbra NYSE:PEN

$321.58 +0.58 (+0.18%)

As of 08/28/2026 03:58 PM Eastern

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Zimmer Biomet NYSE:ZBH

$101.10 +1.62 (+1.63%)

As of 08/28/2026 03:58 PM Eastern

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest ZBH, PEN, BSX, and BDX Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest ZBH, PEN, BSX, and BDX Earnings

Compare Dividends

Latest ZBH, PEN, BSX, and BDX Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

ZBH, PEN, BSX, and BDX Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

ZBH, PEN, BSX, and BDX Company Descriptions

Becton, Dickinson and Company NYSE:BDX

Boston Scientific NYSE:BSX

Penumbra NYSE:PEN

Zimmer Biomet NYSE:ZBH

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools